Efficacy of Sinopharm Vaccine among Stem Cell Transplant Recipient during two peaks of Delta and Omicron variants of COVID-19.
Sign Up to like & getrecommendations! Published in 2022 at "Current drug safety"
DOI: 10.2174/1574886317666220801122822
Abstract: BACKGROUND Considering the dearth of research on the complications of Sinopharm coronavirus disease 2019 (COVID-19) vaccine in the immunocompromised individuals and the lack of available data on COVID-19 vaccination from Iran. OBJECTIVE This study aimed… read more here.
Keywords: variants covid; covid; sinopharm vaccine; sinopharm covid ... See more keywords